Grzegorz Helbig

Katowice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.

Journal: Bone marrow transplantation

Published: April 15, 2026

Leveraging Ensemble Machine Learning Models for the Detection of Primary Myelofibrosis in Electronic Health Records.

Leveraging Ensemble Machine Learning Models for the Detection of Primary Myelofibrosis in Electronic Health Records.

Journal: Cancers

Published: March 25, 2026

Autologous haematopoietic stem cell transplantation in standard-risk T-cell acute lymphoblastic leukaemia/lymphoma with negative residual disease status.

Autologous haematopoietic stem cell transplantation in standard-risk T-cell acute lymphoblastic leukaemia/lymphoma with negative residual disease status.

Journal: Archives of medical science : AMS

Published: January 13, 2026

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party.

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party.

Journal: The Lancet. Haematology

Published: December 28, 2025

AI-driven diagnostic algorithm enhances early detection of paroxysmal nocturnal hemoglobinuria in real-world settings.

AI-driven diagnostic algorithm enhances early detection of paroxysmal nocturnal hemoglobinuria in real-world settings.

Journal: NPJ digital medicine

Published: December 12, 2025

Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.

Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.

Journal: Clinical and experimental medicine

Published: December 10, 2025

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Journal: British journal of haematology

Published: October 09, 2025

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Journal: Annals of hematology

Published: September 20, 2025

"B" symptoms and CBV conditioning negatively impact survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation.

"B" symptoms and CBV conditioning negatively impact survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation.

Journal: Annals of hematology

Published: July 28, 2025

Regulatory T-cell Activation Pathways in Patients With Chronic Graft-versus-host Disease Undergoing Extracorporeal Photopheresis Treatment: A Single-center Pilot Study.

Regulatory T-cell Activation Pathways in Patients With Chronic Graft-versus-host Disease Undergoing Extracorporeal Photopheresis Treatment: A Single-center Pilot Study.

Journal: In vivo (Athens, Greece)

Published: July 02, 2025

Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia.

Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia.

Journal: Expert review of hematology

Published: June 27, 2025

Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Journal: Expert review of hematology

Published: May 23, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026